Induction of stem cell factor/c-Kit/Slug signal transduction in multidrug-resistant malignant mesothelioma cells

被引:77
作者
Catalano, A
Rodilossi, S
Rippo, MR
Caprari, P
Procopio, A
机构
[1] Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies, I-60131 Ancona, Italy
[2] Italian Natl Res Ctr Aging, Lab Cytol, I-60124 Ancona, Italy
[3] NCI, Neural Dev Grp, Mouse Canc Genet Program, NIH, Frederick, MD 21701 USA
关键词
D O I
10.1074/jbc.M406696200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Malignant mesothelioma (MM) is strongly resistant to conventional chemotherapy by unclear mechanisms. We and others have previously reported that cytokine- and growth factor-mediated signal transduction is involved in the growth and progression of MM. Here, we identified a pathway that involves stem cell factor (SCF)/c-Kit/Slug in mediating multidrug resistance of MM cells. When we compared gene expression profiles between five MM cells and their multidrug-resistant (MM DX) sublines, we found that MM DX cells expressed both SCF and c-Kit and had higher mRNA levels of Slug. Knockdown of c-Kit or Slug expression with their respective small interfering RNA sensitized MM DX cells to the induction of apoptosis by different chemotherapeutic agents, including doxorubicin, paclitaxel, and vincristine. Transfection of c-Kit in parental MM cells in the presence of SCF up-regulated Slug and increased resistance to the chemotherapeutic agents. Moreover, MM cells expressing Slug showed a similar increased resistance to the chemotherapeutic agents. These results indicate that induction of Slug by autocrine production of SCF and c-Kit activation plays a key role in conferring a broad spectrum chemoresistance on MM cells and reveal a novel signal transduction pathway for pharmacological or genetic intervention of MM patients.
引用
收藏
页码:46706 / 46714
页数:9
相关论文
共 47 条
  • [1] Hemopoietic growth factor receptor abnormalities in leukemia
    Alexander, WS
    Nicola, NA
    [J]. LEUKEMIA RESEARCH, 1998, 22 (12) : 1097 - 1111
  • [2] Multidrug resistance - A multiplex phenomenon
    Baldini, N
    [J]. NATURE MEDICINE, 1997, 3 (04) : 378 - 380
  • [3] The pathogenesis of mesothelioma
    Carbone, M
    Kratzke, RA
    Testa, JR
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (01) : 2 - 17
  • [4] Experimental therapy of malignant mesothelioma: new perspectives from anti-angiogenic treatments
    Catalano, A
    Gianni, W
    Procopio, A
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 50 (02) : 101 - 109
  • [5] Reclinical evaluation of the nonsteroidal anti-inflammatory agent celecoxib on malignant mesothelioma chemoprevention
    Catalano, A
    Graciotti, L
    Rinaldi, L
    Raffaelli, G
    Rodilosso, S
    Betta, P
    Gianni, W
    Amoroso, S
    Procopio, A
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (03) : 322 - 328
  • [6] Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen
    Catalano, A
    Romano, M
    Martinotti, S
    Procopio, A
    [J]. ONCOGENE, 2002, 21 (18) : 2896 - 2900
  • [7] Methionine aminopeptidase-2 regulates human mesothelioma cell survival - Role of bcl-2 expression and telomerase activity
    Catalano, A
    Romano, M
    Robuffo, I
    Strizzi, L
    Procopio, A
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (02) : 721 - 731
  • [8] Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
    Cavallaro, U
    Christofori, G
    [J]. NATURE REVIEWS CANCER, 2004, 4 (02) : 118 - 132
  • [9] STEEL FACTOR INFLUENCES THE DISTRIBUTION AND ACTIVITY OF MURINE HEMATOPOIETIC STEM-CELLS INVIVO
    FLEMING, WH
    ALPERN, EJ
    UCHIDA, N
    IKUTA, K
    WEISSMAN, IL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) : 3760 - 3764
  • [10] IDENTIFICATION OF MUTATIONS IN THE CODING SEQUENCE OF THE PROTOONCOGENE C-KIT IN A HUMAN MAST-CELL LEUKEMIA-CELL LINE CAUSING LIGAND-INDEPENDENT ACTIVATION OF C-KIT PRODUCT
    FURITSU, T
    TSUJIMURA, T
    TONO, T
    IKEDA, H
    KITAYAMA, H
    KOSHIMIZU, U
    SUGAHARA, H
    BUTTERFIELD, JH
    ASHMAN, LK
    KANAYAMA, Y
    MATSUZAWA, Y
    KITAMURA, Y
    KANAKURA, Y
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) : 1736 - 1744